European regulatory experience with drugs for central nervous system disorders

被引：0

作者：

Florence Butlen-Ducuing

Malgorzata Zienowicz

Frank Pétavy

Manuel Haas

Tomas Salmonson

Hans-Georg Eichler

Guido Rasi

机构：

[1] European Medicines Agency,

[2] Medical Products Agency,undefined

[3] SE-751 03 Uppsala,undefined

[4] Sweden,undefined

[5] and is Chair of the CHMP.,undefined

来源：

Nature Reviews Drug Discovery | 2015年 / 14卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Butlen-Ducuing and colleagues analyse ~20 years of data on regulatory applications assesssed by the European Medicines Agency in psychiatry and neurology, with the aim of illuminating challenges that underlie the 'pipeline problem' for drugs for central nervous system disorders.

引用

页码：89 / 90

页数：1

共 50 条

[31] EFFECTS OF ANAESTHETIC DRUGS ON CENTRAL NERVOUS SYSTEM
ROBSON, JG
[J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1971, 64 (02): : 211 - +
[32] EFFECTS OF THALIDOMIDE ON CENTRAL NERVOUS SYSTEM DRUGS
KUHN, WL
VANMAANEN, EF
[J]. FEDERATION PROCEEDINGS, 1960, 19 (01) : 264 - 264
[33] DRUGS AND THE DEVELOPING CENTRAL NERVOUS-SYSTEM
VERNADAKIS, A
PARKER, KK
[J]. PHARMACOLOGY & THERAPEUTICS, 1980, 11 (03) : 593 - 647
[34] Delivering drugs to the central nervous system: an overview
Dickson, Patricia I.
[J]. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (03) : 145 - 151
[35] Pharmacogenomics of Central Nervous System (CNS) Drugs
Cacabelos, Ramon
[J]. DRUG DEVELOPMENT RESEARCH, 2012, 73 (08) : 461 - 476
[36] Delivering drugs to the central nervous system: an overview
Patricia I. Dickson
[J]. Drug Delivery and Translational Research, 2012, 2 : 145 - 151
[37] Central nervous system pharmacokinetics of psychiatric drugs
Salazar, DE
Fischman, AJ
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 : 10S - 12S
[38] "Wonder drugs" in central nervous system lymphoma
Korfel, Agnieszka
[J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S158 - S162
[39] Discontinued drugs in 2006: central and peripheral nervous system drugs
Collins, Susanne D.
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (11) : 1743 - 1751
[40] Discontinued drugs 2007: central and peripheral nervous system drugs
Ebert, Bjarke
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (02) : 109 - 123

← 1 2 3 4 5 →